Pharming gets positive results from final analysis of Rhucin studies
Monday, July 06, 2009 14:00 IST Leiden, The Netherlands
Biotech company Pharming Group NV announced that, as part of the activities for the regulatory submission files, it has now also completed the final analysis of its Rhucin randomised placebo-controlled studies.
